Samir Rashmikant Patel - Jan 1, 2024 Form 3 Insider Report for Akari Therapeutics Plc (AKTX)

Role
Director
Signature
/s/ Rachelle Jacques, as Attorney-in-Fact for Samir Patel
Stock symbol
AKTX
Transactions as of
Jan 1, 2024
Transactions value $
$0
Form type
3
Date filed
1/2/2024, 07:56 PM
Previous filing
Nov 30, 2021
Next filing
Jun 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AKTX Ordinary Shares, par value $0.0001 per share 2.09B Jan 1, 2024 PranaBio Investments LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AKTX Warrants (Right to Buy) Jan 1, 2024 Ordinary Shares, par value $0.0001 per share 32.5M $0.03 PranaBio Investments LLC
holding AKTX Warrants (Right to Buy) Jan 1, 2024 Ordinary Shares, par value $0.0001 per share 25M $0.02 PranaBio Investments LLC
holding AKTX Warrants (Right to Buy) Jan 1, 2024 Ordinary Shares, par value $0.0001 per share 5M $0.02 PranaBio Investments LLC
holding AKTX Warrants (Right to Buy) Jan 1, 2024 Ordinary Shares, par value $0.0001 per share 12.5M $0.02 PranaBio Investments LLC
holding AKTX Warrants (Right to Buy) Jan 1, 2024 Ordinary Shares, par value $0.0001 per share 50M $0.01 PranaBio Investments LLC
holding AKTX Warrants (Right to Buy) Jan 1, 2024 Ordinary Shares, par value $0.0001 per share 150M $0.01 PranaBio Investments LLC
holding AKTX Warrants (Right to Buy) Jan 1, 2024 Ordinary Shares, par value $0.0001 per share 150M $0.01 PranaBio Investments LLC
holding AKTX Warrants (Right to Buy) Jan 1, 2024 Ordinary Shares, par value $0.0001 per share 96.8M $0.00 PranaBio Investments LLC F1
holding AKTX Stock Option (Right to Buy) Jan 1, 2024 Ordinary Shares, par value $0.0001 per share 5M $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pre-funded warrants exercisable until exercised in full.
F2 Non-qualified stock option granted under the Issuer's 2023 Equity Incentive Plan. The stock option vests and becomes exercisable ratably in three equal installments with the first installment vesting on the date of the first Annual General Meeting ("AGM") following the date of the grant, and with the second and third installments vesting, respectively, on the dates of the second and third AGM's following the date of the grant, subject to the non-employee director's continued service with the Issuer.

Remarks:

See Exhibit 24.1 - Power of Attorney